The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added to a ...

GSK, led by boss Emma Walmsley (pictured), is using the data of 1.4m adults aged 65 and 66 to examine the impact of its ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

UK pharma major GSK (LSE: GSK) today announced a major new research collaboration with the UK Dementia Research Institute (UK ...

At present, Shingrix is used to prevent herpes zoster (shingles), a painful skin rash caused by the varicella-zoster virus.

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

The British drugmaker is using the health data of some 1.4 million people, some of whom received its Shingrix shot and some ...

Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...

GSK has announced a partnership with the UK Dementia Research Institute and Health Data Research UK to explore a potential ...

To test it prospectively, GSK will work with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) ...